The Motley Fool

Why the Loblaw (TSX:L) Stock Price Fell 2.5% in February

Image source: Getty Images

It is an important exercise to periodically review the performance of our stock holdings as well as those stocks that are on our watch lists. This review should happen at least once a year but also when we notice big stock price movements.

Let’s review Loblaw Companies’s (TSX:L) stock price.

Loblaw benefits from defensive, risk-averse sentiment as coronavirus fears spark stock market crash

Loblaw’s stock price fell only slightly in February, and while this may seem unimpressive at first glance, when we consider the fact that this was a month that saw the S&P/TSX Composite Index beaten down significantly, it becomes clear that Loblaw stock is shining. In fact, markets globally were down significantly as well, highlighting the fact that Loblaw stock is an attractive one for preservation of capital, which is a very appealing quality these days.

So, fears of a spreading coronavirus and its impact on demand and the health of global economies have clearly had a toll on markets. And that’s not even mentioning general fears for our health regardless of financial markets, all of which can easily shift investor sentiment down a slippery slope of negativity.

From Loblaw’s exposure to the consumer staples sector to its exposure to the healthcare business, Loblaw stock is set up nicely to ride the storms of uncertainty and economic hardship. Loblaw stock is therefore a leading defensive Canadian stock to own.

Loblaw’s stock price is supported by strong financial results

February saw the release of Loblaw’s fourth-quarter and year-end 2019 results. Despite the fact that the results were slightly worse than expected, it is clear that the company is setting itself up to benefit from its leading market position in the discount grocery segment; with banners such as No Frills and Maxi fending off competition from the likes of Walmart. Furthermore, Loblaw’s strong private label brands and leading market share in prescriptions and front-of-store sales at Shoppers Drug Mart all work to solidify the company’s value proposition and its free cash flow generation.

So, while the latest quarter was slightly disappointing, Loblaw still generated free cash flow of approximately $1.2 billion, with a significant portion of that being used to return capital to shareholders by buying back 13.6 million shares (3.6% of shares outstanding as of December 2018). And we can expect free cash flow in excess of $1 billion annually going forward, as the company’s predictable and defensive business continues to provide consumers with essential everyday products.

Foolish bottom line

Loblaw stock has held up exceptionally well in this difficult environment, as we would expect. Going forward, we can feel confident that Loblaw should continue to be a safe bet for our investment portfolios, as the company continues to dominate the food retail and pharmacy landscape here in Canada.

In closing, I would like to remind Foolish investors of our belief in holding great businesses for the long term. While this belief remains intact, we are also aware that sometimes, short-term stock price movements create opportunities to create wealth. By blending this long-term focus with a keen eye for short-term stock mispricings, we can use both strategies in harmony, and our quest for financial freedom can be fulfilled.

The 10 Best Stocks to Buy This Month

Renowned Canadian investor Iain Butler just named 10 stocks for Canadians to buy TODAY. So if you’re tired of reading about other people getting rich in the stock market, this might be a good day for you.

Because Motley Fool Canada is offering a full 65% off the list price of their top stock-picking service, plus a complete membership fee back guarantee on what you pay for the service. Simply click here to discover how you can take advantage of this.

Click Here to Learn More Today!

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Karen Thomas has no position in any of the stocks mentioned.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss an important event.

Iain Butler and the Stock Advisor Canada team only publish their new “buy alerts” twice a month, and only to an exclusively small group.

This is your chance to get in early on what could prove to be very special investment advice.

Enter your email address below to get started now, and join the other thousands of Canadians who have already signed up for their chance to get the market-beating advice from Stock Advisor Canada.